Radiotherapy & Oncology
Volume 91, Issue 1 , Pages 23-32 , April 2009

Radiotherapy to the chest wall following mastectomy for node-negative breast cancer: A systematic review

  • Nicholas P. Rowell

      Affiliations

    • Corresponding Author InformationAddress: Kent Oncology Centre, Maidstone Hospital, Hermitage Lane, Maidstone, Kent ME16 9QQ, UK.

Received 19 June 2008 ,Revised 15 September 2008 ,Accepted 24 September 2008.

References 

  1. Goldhirsch A, Wood WC, Gelber RD, et al. Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol. 2007;18:1133–1144
  2. Recht A, Edge SB, Solin LJ, et al. Postmastectomy radiotherapy: guidelines of the American Society of Clinical Oncology. J Clin Oncol. 2001;19:1539–1569
  3. Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. Can Med Assoc J. 2004;170:1263–1273
  4. Cuzick J, Stewart H, Peto R, et al. Overview of randomised trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep. 1987;71:15–29
  5. Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;366:2087–2106
  6. Olivotto IA, Truong PT. Postmastectomy radiation therapy: who needs it?. J Clin Oncol. 2004;22:4237–4239
  7. Barton M. Tables of equivalent dose in 2Gy fractions: a simple application of the linear–quadratic equation. Int J Radiat Oncol Biol Phys. 1995;31:371–378
  8. Joiner MC, van der Kogel AJ. The linear–quadratic approach to fractionation and calculation of iso-effect relationships. In: Basic clinical radiobiology. 2nd ed. London: Arnold; 1997.
  9. Gelman R, Gelber R, Henderson IC, Coleman CN, Harris JR. Improved methodology for analysing local and distant recurrence. J Clin Oncol. 1990;8:548–555
  10. Gebski V, Lagleva M, Keech A, Simes J, Langlands AO. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective. J Nat Cancer Inst. 2006;98:26–38
  11. Overgaard M. Overview of randomised trials in high risk breast cancer patients treated with adjuvant systemic therapy with or without postmastectomy irradiation. Semin Radiat Oncol. 1999;9:292–299
  12. Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol. 2000;18:1220–1229
  13. Høst H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer – long-term results from the Oslo study. Int J Radiat Oncol Biol Phys. 1986;12:727–732
  14. Friedl W, Scheurlen HR, Henningsen B. The value of radiotherapy after modified radical mastectomy. 10-year results of the Heidelberg study. Dtsch Med Wochenschr. 1983;108:325–330
  15. Tennvall-Nittby L, Tengrup I, Landberg T. The total incidence of loco-regional recurrence in a randomised trial of breast cancer TNM stage II. The South Sweden Breast Cancer Trial. Acta Oncol. 1993;32:641–646
  16. Killander F, Anderson H, Rydén S, et al. Radiotherapy and tamoxifen after mastectomy in postmenopausal women – 20 year follow-up of the South Sweden Breast Cancer Group randomised trial SSBCG II:I. Eur J Cancer. 2007;43:2100–2108
  17. Arriagada R, Rutqvist LE, Mattsson A, Kramar A, Rotstein S. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol. 1995;13:2869–2878
  18. Klefström P, Gröhn P, Heinonen E, Holsti L, Holsti P. Adjuvant postoperative radiotherapy, chemotherapy, and immunotherapy in stage III breast cancer. Cancer. 1987;60:936–942
  19. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. New Engl J Med. 1997;337:949–955
  20. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  21. Rutqvist LE, Pettersson D, Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long term follow-up of a randomised clinical trial. Radiother Oncol. 1993;26:100–104
  22. Ahlborn TN, Gump FE, Bodian C, Habif DV, Kister S. Tumour to fascia margin as a factor in local recurrence after modified radical mastectomy. Surg Gynecol Obst. 1988;166:523–526
  23. Beenken SW, Urist MM, Zhang Y, et al. Axillary lymph node status, but not tumour size, predicts locoregional recurrence and overall survival after mastectomy for breast cancer. Ann Surg. 2003;5:732–739
  24. Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy: incidence and outcomes. J Am Coll Surg. 2006;203:469–474
  25. Ernst MF, Voogd AC, Coebergh JWW, Poortmans PM, Roukema JA. Using loco-regional recurrence as an indictor of the quality of breast cancer treatment. Eur J Cancer. 2004;40:487–493
  26. Jager JJ, Volovics L, Schouten LJ, et al. Loco-regional recurrences after mastectomy in breast cancer: prognostic factors and implications for postoperative irradiation. Radiother Oncol. 1999;50:267–275
  27. Jagsi R, Raad RA, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node-negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–1039
  28. Janni W, Dimpfl T, Braun S, et al. Radiotherapy of the chest wall following mastectomy for early-stage breast cancer: impact on local recurrence and overall survival. Int J Radiat Oncol Biol Phys. 2000;48:967–975
  29. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–2827
  30. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomised trials. J Clin Oncol. 2001;19:1688–1697
  31. Wallgren A, Bonetti M, Gelber RD, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group trials I through VII. J Clin Oncol. 2003;21:1205–1213
  32. Karlsson P, Cole BF, Price KN, et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol. 2007;25:2019–2026
  33. Yau TK, Chang TY, Soong S, et al. Postmastectomy locoregional recurrence in Hong Kong: low risk patients without radiotherapy have more failures than intermediate risk patients with radiotherapy. Presented at 30th San Antonio Breast Cancer Symposium; 2007 [Abstract 4094].
  34. Yildrim E, Berberoglu U. Can a subgroup of node-negative breast carcinoma patients with T1–2 tumour who may benefit from postmastectomy radiotherapy be identified?. Int J Radiat Oncol Biol Phys. 2007;68:1024–1029
  35. Taghian AG, Jeong JH, Mamounas EP, et al. Low locoregional recurrence rate among node-negative breast cancer patients with tumours 5cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomised clinical trials. J Clin Oncol. 2006;24:3927–3932
  36. Floyd SR, Buchholz TA, Haffty BG, et al. Low local recurrence rate without postmastectomy radiation in node-negative breast cancer patients with tumours 5cm and larger. Int J Radiat Oncol Biol Phys. 2006;66:358–364
  37. Helintö M, Blomqvist C, Heikkilä P, Joensuu H. Post-mastectomy radiotherapy in pT3N0M0 breast cancer: is it needed?. Radiother Oncol. 1999;52:213–217
  38. Mok TSK, Kwan WH, Yeo WM, et al. Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer. Radiother Oncol. 2000;54:201–208
  39. Aksu G, Kucucuk S, Fayda M, et al. The role of postoperative radiotherapy in node negative breast cancer patients with pT3–T4 disease. Eur J Surg Oncol. 2007;33:285–293
  40. Truong PT, Olivotto IA, Speers CH, Wai ES, Berthelet E, Kader HA. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer. Int J Radiat Oncol Biol Phys. 2004;58:797–804
  41. Truong PT, Yong CM, Abnousi F, et al. Lymphovascular invasion is associated with reduced locoregional control and survival in women with node-negative breast cancer treated with mastectomy and systemic therapy. J Am Coll Surg. 2005;200:912–921
  42. Freedman GM, Fowble BL, Hanlon AL, et al. A close or positive margin after mastectomy is not an indication for chest wall irradiation except in women aged fifty or younger. Int J Radiat Oncol Biol Phys. 1998;41:599–605
  43. Mentzer SJ, Osteen RT, Wilson RE. Local recurrence and the deep resection margin in carcinoma of the breast. Surg Gynecol Obst. 1986;163:513–517
  44. Højris I, Overgaard M, Christensen JJ, et al. Morbidity and mortality of ischaemic heart disease in high-risk breast cancer patients after adjuvant post-mastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Lancet. 1999;354:1425–1430
  45. Van de Steene J, Vinh-Hung V, Cutuli B, Storme G. Adjuvant radiotherapy for breast cancer: effects of longer follow-up. Radiother Oncol. 2004;72:35–43
  46. Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet. 1993;341:418–422
  47. Nielsen HM, Overgaard M, Grau C, Jensen AR, Overgaard J. Loco-regional recurrence after mastectomy in high-risk breast cancer – risk and prognosis. An analysis of patients from the DBCG 82 b&c randomisation trials. Radiother Oncol. 2006;79:147–155
  48. Early Breast Cancer Trialists’ Collaborative Group. Chemotherapy and hormonal therapy for early breast cancer: effects of recurrence and 15-year survival in an overview of the randomised trials. Lancet 2005;365:1687–717.
  49. Kaufman EL, Jacobson JS, Hershman DL, Desai M, Neugut AI. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol. 2008;26:392–398
  50. Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN, Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst. 2005;97:419–424
  51. Katz A, Strom EA, Buchholz TA, et al. The influence of pathologic tumour characteristics on locoregional recurrence rates following mastectomy. Int J Radiat Oncol Biol Phys. 2001;50:735–742
  52. Wilson CB, Haba Y, Wishart GC. The identification of patients for post-mastectomy radiotherapy using the Cambridge index: audit of a prospective series. Presented at 30th San Antonio Breast Cancer Symposium; 2007 [Abstract 4093].
  53. Kunkler IH, Canney P, van Tienhoven G, et al. Elucidating the role of chest wall irradiation in ‘intermediate-risk’ breast cancer: the MRC/EORTC SUPREMO trial. Clin Oncol. 2008;20:31–34
  54. Available from: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/Speaker?&spk=Darby%2C+Sarah+%5Bfau%5D.

☆ Funding sources. Dr. N.P. Rowell is employed by Maidstone & Tunbridge Wells NHS Trust. There are no additional sources of funding.

PII: S0167-8140(08)00520-3

doi: 10.1016/j.radonc.2008.09.026

Radiotherapy & Oncology
Volume 91, Issue 1 , Pages 23-32 , April 2009

Article Tools

* Image Usage & Resolution